The National Institute for Health and Care Excellence says it’s not been commissioned to produce guidelines for the diagnosis and treatment of Tourette's syndrome, but it is currently assessing ...

The directors of Asarina Pharma have abandoned a search for a partner for Tourette's syndrome treatment sepranolone, saying they have no choice but to liquidate the company. Just over a year ago ...

A 'zapper' worn on the wrist that slashes symptoms of the speaking disorder Tourette's syndrome could be rolled ... of young ...

If successful, this work has the potential to lead to a new treatment option for people with Tourette syndrome in the future. The trial will begin recruiting participants this spring. About the ...

Prompt detection of Tourette syndrome is important to help people manage the condition, Dy-Hollins said. "Treatment options include education, behavioral therapies, medication and watchful waiting ...

Relmada has acquired Sepranolone, a Phase 2b ready asset, which positions the company to potentially offer a new first-line treatment for Tourette syndrome and other compulsion-related conditions.

Tourette syndrome is currently diagnosed about three ... in Boston and a member of the American Academy of Neurology. "Treatment options include education, behavioral therapies, medication and ...

Sepranolone is a neurosteroid being developed as a potential treatment for Tourette's syndrome (TS) and other compulsive disorders. TS is a complex neurological condition characterised by ...

Background and Objective: Tourette's syndrome is a relatively common biological genetic disorder with a broad spectrum of neurobehavioural manifestations. Unfortunately, treatment of the condition ...